Key points are not available for this paper at this time.
The lack of competition in the surgical robots market may mean that this technology represents a poorer deal than it need do for healthcare buyers—ultimately patients, insurance companies, and taxpayers, write Abhishek Trehan and Tristan J Dunn
Trehan et al. (2013) studied this question. The lack of competition in the surgical robots market represents a poor deal for healthcare buyers, patients, and taxpayers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: